Tag: iuds market size

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Hormonal Intrauterine Devices (IUDs) Market Size And Revenue Outlook Through 2030

The market size for hormonal intrauterine devices (IUDs) has experienced substantial growth in recent years. This market is projected to expand from $2.87 billion in 2025 to $3.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. In the past, this expansion has been fueled by factors including greater public awareness of family planning alternatives, the broadening of women’s reproductive healthcare initiatives, a growing preference for enduring contraception, the accessibility of hormone-based devices, and backing from public health programs.

The market for hormonal intrauterine devices (IUDs) is projected to experience swift expansion over the coming years. This market is anticipated to reach $4.74 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Several factors are driving this growth during the forecast period, including a heightened demand for non-surgical contraceptive options, a greater emphasis on menstrual health management, broader access in developing markets, increased investments in women’s health technologies, and continuous innovation in hormone delivery systems. Key trends for the forecast period encompass the rising adoption of low-dose hormonal IUDs, increasing preference for long-acting reversible contraceptives, a growing inclination towards frameless device designs, the broadening of therapeutic IUD applications, and a stronger emphasis on patient comfort and safety.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=79252501&type=smp&name=Hormonal%20Intrauterine%20Devices%20%28IUDs%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hormonal Intrauterine Devices (IUDs) Market Opportunity Drivers: What’s Unlocking New Revenue Potential?

The increasing prevalence of unwanted pregnancies is anticipated to drive the expansion of the hormonal intrauterine devices market. Unwanted pregnancies are those not deliberately planned or wished for at the moment of conception. These can arise from multiple factors, including the ineffectiveness of contraceptive methods, insufficient access to birth control, improper use of contraception, or experiences of sexual violence. Limited availability of reliable contraception heightens the risk of unwanted pregnancies by lessening individuals’ autonomy over their reproductive choices. Hormonal IUDs are exceptionally effective at preventing pregnancy, with a failure rate under 1%. They deliver long-term protection, typically ranging from 3 to 7 years depending on the device, positioning them as a trustworthy choice for individuals aiming to prevent unwanted pregnancies. For instance, in July 2025, the Society for Family Planning, a US-based professional organization, stated that abortions increased to 1.14 million in 2024, compared with 1.05 million recorded in 2023. Therefore, the surge in unwanted pregnancies is a primary factor fueling the growth of the hormonal intrauterine devices market.

Hormonal Intrauterine Devices (IUDs) Market Segment Analysis: What Are The Core Market Categories?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

Hormonal Intrauterine Devices (IUDs) Market Innovation Trends Shaping Future Development

Major companies in the hormonal intrauterine devices market are focusing on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. Levonorgestrel intrauterine devices (IUDs) are long-term birth control options inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions, providing up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect stems from its capability to increase the density of cervical mucus, thus preventing sperm from reaching the uterus. For heavy bleeding, it functions by thinning the uterine lining, which helps reduce menstrual flow.

Hormonal Intrauterine Devices (IUDs) Market Industry Leaders And Competitive Landscape

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

View The Full Hormonal Intrauterine Devices (IUDs) Market Report:

https://thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Hormonal Intrauterine Devices (IUDs) Market Regional Analysis And Top Geography

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The hormonal intrauterine devices (IUDs) market has witnessed significant expansion recently, reflecting a growing preference for effective long-term contraceptive options. Rising awareness about family planning and advancements in women’s reproductive health are contributing to this rapid growth. Here, we explore the current market size, key growth drivers, important market segments, industry trends, major players, and regional outlook shaping the future of hormonal IUDs.

Market Size and Projected Growth in the Hormonal Intrauterine Devices Market

The hormonal intrauterine devices market has shown impressive growth, expanding from $2.87 billion in 2025 to an expected $3.18 billion in 2026, with a compound annual growth rate (CAGR) of 10.6%. This growth reflects increasing awareness of family planning choices, broader reproductive healthcare initiatives, a rising preference for long-acting contraceptive methods, and greater availability of hormone-based intrauterine devices. Public health programs supporting contraception have also played a crucial role in this expansion. Looking ahead, the market is forecasted to reach $4.74 billion by 2030, growing at a steady CAGR of 10.5%. The anticipated growth is fueled by a surge in demand for non-surgical contraceptive methods, increased attention to menstrual health management, wider access in developing regions, and continuous innovation in hormone delivery technologies. Notable trends include greater adoption of low-dose hormonal IUDs, rising interest in long-acting reversible contraceptives, increasing popularity of frameless IUD designs, expanded therapeutic uses, and a heightened focus on patient comfort and safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Factors Fueling Hormonal Intrauterine Devices Market Expansion

A significant contributor to the hormonal IUD market growth is the rising incidence of unwanted pregnancies worldwide. Unintended pregnancies, defined as those not planned or desired at conception, can result from contraceptive failure, limited access to birth control, incorrect usage, or even sexual violence. Restricted availability of effective contraception diminishes individuals’ control over their reproductive choices, thereby increasing the risk of unplanned pregnancies. Hormonal IUDs, known for their high efficacy with a failure rate of less than 1%, offer reliable, long-term contraception ranging from 3 to 7 years depending on the type. For example, data from the Society for Family Planning in July 2025 highlighted an increase in abortions in the US to 1.14 million in 2024, up from 1.05 million in 2023. This rise in unintended pregnancies directly stimulates demand for hormonal IUDs as a preventive measure.

Market Segmentation Reveals Key Opportunities Within the Hormonal IUD Industry

This market is categorized across several dimensions to capture its full diversity. The segments include:

1) Type of hormonal IUD: 13 milligram, 19 milligram, and 52 milligram devices

2) Device design: framed and frameless intrauterine devices

3) Hormone type: levonorgestrel-releasing and progesterone-releasing IUDs

4) Application by age groups: 20-24 years, 25-34 years, 35-44 years, and other uses

Further subcategories break down into distinctions such as low-dose versus specialty devices within each milligram grouping. For example, 13 mg IUDs include low-dose and specialty options for specific medical conditions. The 19 mg devices are similarly divided, while 52 mg IUDs include standard, extended-release, and specialty devices designed to address heavy menstrual bleeding or endometriosis.

Access The Complete Hormonal Intrauterine Devices (IUDs) Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Current Industry Trends Advancing Hormonal Intrauterine Devices Market Growth

Leading players in the hormonal IUD space are focusing on creating advanced solutions that not only prevent pregnancy but also address menstrual health issues. Levonorgestrel-releasing IUDs are gaining traction as they offer long-term contraception while helping reduce menstrual bleeding and cramps. For instance, in October 2024, the US nonprofit Medicines360 introduced Avibela, a 52 mg levonorgestrel IUD in Zambia. This device provides up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. It works by thickening cervical mucus to block sperm and thinning the uterine lining to lessen menstrual flow.

Competitive Landscape of Key Players in the Hormonal IUD Market

Several major companies are actively competing and innovating in the hormonal intrauterine devices market. Prominent industry participants include Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., and Shanghai Chuangling Medical Devices Co. Ltd. These companies focus on expanding product portfolios, enhancing hormone delivery technologies, and increasing market penetration globally.

Regional Outlook Highlights North America’s Lead and Asia-Pacific’s Rapid Growth

In 2025, North America dominated the hormonal intrauterine devices market, holding the largest regional share. However, the Asia-Pacific region is projected to experience the fastest growth throughout the forecast period. The market analysis encompasses major regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on evolving demand and regional dynamics.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Hormonal Intrauterine Devices (IUDs) Market From 2026 To 2030?

The market size for hormonal intrauterine devices (iuds) has expanded significantly in recent years. This market is projected to grow from $2.87 billion in 2025 to $3.18 billion in 2026, at a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to heightened awareness regarding family planning options, the expansion of women’s reproductive healthcare programs, a rising preference for long-term contraception, the increasing availability of hormone-based devices, and strong support from public health initiatives.

The market size for hormonal intrauterine devices (iuds) is anticipated to experience significant expansion over the upcoming years. It is projected to reach $4.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is fueled by factors such as the increasing demand for non-surgical contraceptive alternatives, an elevated focus on menstrual health management, wider access in emerging markets, rising investments in women’s health technologies, and continued innovation in hormone delivery systems. Prominent trends throughout the forecast period include the growing adoption of low-dose hormonal iuds, an increasing need for long-acting reversible contraceptives, a developing preference for frameless device designs, the broadening of therapeutic iud applications, and an intensified emphasis on patient comfort and safety.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

What Primary Factors Are Fueling The Expansion Of The Hormonal Intrauterine Devices (IUDs) Market?

The growing prevalence of unintended pregnancies is anticipated to drive the expansion of the hormonal intrauterine devices market. Unintended pregnancies are defined as those not planned or desired when conception occurs. Such pregnancies can result from various factors, including contraceptive failures, insufficient access to birth control methods, incorrect use of contraception, or instances of sexual violence. When access to effective contraception is restricted, it escalates the likelihood of unintended pregnancies by diminishing individuals’ autonomy over their reproductive choices. Hormonal IUDs demonstrate high effectiveness in preventing pregnancy, boasting a failure rate of less than 1%. These devices offer sustained protection for 3 to 7 years, depending on the specific type, presenting a reliable option for individuals aiming to prevent unwanted pregnancies. For instance, in July 2025, data from the Society for Family Planning, a professional body based in the US, indicated a rise in abortions to 1.14 million in 2024, up from 1.05 million recorded in 2023. Consequently, the increasing incidence of unwanted pregnancies is a key factor propelling the growth of the hormonal intrauterine devices market.

How Is Segment Classification Applied In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Influencing The Future Of The Hormonal Intrauterine Devices (IUDs) Market?

Prominent companies in the hormonal intrauterine devices market are concentrating on developing sophisticated products, such as levonorgestrel intrauterine devices (IUDs), aimed at alleviating menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) serve as extended-duration birth control solutions, implanted into the uterus to gradually release the hormone levonorgestrel and prevent pregnancy. For example, in October 2024, Medicines360, a nonprofit organization based in the US, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD), in Zambia. This device offers two primary benefits: up to eight years of pregnancy avoidance and up to five years of reduction in heavy menstrual bleeding. Its contraceptive action stems from its capacity to increase the density of cervical mucus, thereby stopping sperm from accessing the uterus. For managing heavy bleeding, it functions by thinning the uterine lining, which contributes to a decrease in menstrual flow.

Who Are The Leading Firms Participating In The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Access The Complete Hormonal Intrauterine Devices (IUDs) Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Which Region Holds The Largest Share In The Hormonal Intrauterine Devices (IUDs) Market?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Hormonal Intrauterine Devices (IUDs) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Hormonal Intrauterine Devices (IUDs) Market In 2026, And How Will Its Value Evolve By 2030?

The market size for hormonal intrauterine devices (iuds) has expanded significantly in recent years. It will grow from $2.87 billion in 2025 to $3.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. Historically, this expansion has been driven by factors such as enhanced knowledge of family planning choices, broader women’s reproductive health initiatives, a greater inclination towards long-acting birth control, the presence of hormonal device options, and backing from public health campaigns.

The market for Hormonal Intrauterine Devices (IUDs) is poised for substantial expansion over the next few years. It is projected to reach $4.74 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 10.5%. This expected market growth can be attributed to several factors, including the increasing demand for non-surgical contraceptive methods, a greater emphasis on menstrual health management, the broadening of access in developing markets, rising investments in women’s health technologies, and continued innovation in hormone delivery systems. Key trends anticipated during this period involve the increasing uptake of low-dose hormonal IUDs, a surging preference for long-acting reversible contraceptives, a growing demand for frameless device designs, the expansion of therapeutic IUD applications, and an intensified focus on patient comfort and safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Which Important Drivers Are Guiding The Hormonal Intrauterine Devices (IUDs) Market Growth?

The rising incidence of unplanned pregnancies is projected to drive expansion within the hormonal intrauterine devices market. Unplanned pregnancies are defined as conceptions that were not intended or wished for at the moment they occurred. Multiple factors contribute to these pregnancies, such as the failure of contraception, insufficient availability of birth control, improper application of contraceptive methods, or instances of sexual violence. Restricted availability of reliable contraception escalates the likelihood of unplanned pregnancies, diminishing individuals’ autonomy regarding their reproductive decisions. Hormonal IUDs demonstrate high efficacy in pregnancy prevention, boasting a failure rate of less than 1%. These devices offer extended protection, lasting 3 to 7 years, contingent on the specific type, making them a dependable choice for individuals aiming to prevent unplanned conceptions. As an illustration, in July 2025, data from the Society for Family Planning, a US professional body, indicated that abortions increased to 1.14 million in 2024, up from 1.05 million documented in 2023. Consequently, the surge in unplanned pregnancies is fueling expansion in the hormonal intrauterine devices market.

How Are Different Segments Classified In The Hormonal Intrauterine Devices (IUDs) Market Segment Analysis?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Influencing The Evolution Of The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies in the hormonal intrauterine devices market are concentrating on developing enhanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) are long-acting birth control options placed inside the uterus, continuously releasing the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions: providing up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect is achieved by making cervical mucus denser, which stops sperm from reaching the uterus. For heavy bleeding, it works by thinning the uterine lining, thereby helping to reduce menstrual flow.

Who Are The Companies Driving Activity In The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Get The Full Hormonal Intrauterine Devices (IUDs) Market Report:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Where Is The Hormonal Intrauterine Devices (IUDs) Market Most Concentrated Geographically?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hormonal Intrauterine Devices (IUDs) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Hormonal Intrauterine Devices (IUDs) Market Across 2026–2030?

The market size for hormonal intrauterine devices (IUDs) has seen rapid growth in recent years. It is forecast to increase from $2.87 billion in 2025 to $3.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.6%. This historical expansion can be attributed to a combination of factors including growing awareness of family planning options, the expansion of women’s reproductive healthcare programs, a rising preference for long-term contraception, the availability of hormone-based devices, and support from public health initiatives.

The market size for hormonal intrauterine devices (IUDs) is anticipated to experience rapid growth over the next few years. It is projected to expand to $4.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is attributed to the increasing demand for non-surgical contraceptive solutions, a rising focus on menstrual health management, the expansion of access in emerging markets, growing investments in women’s health technologies, and increasing innovation in hormone delivery systems. Significant trends expected in this period include the increasing adoption of low-dose hormonal IUDs, a rising demand for long-acting reversible contraceptives, a growing preference for frameless device designs, the expansion of therapeutic IUD applications, and an enhanced focus on patient comfort and safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Hormonal Intrauterine Devices (IUDs) Market?

The rising incidence of unplanned pregnancies is anticipated to stimulate the expansion of the hormonal intrauterine devices market moving ahead. Unwanted pregnancies are defined as those not intended or wished for at the point of conception. Such pregnancies can arise due to multiple factors, such as failed contraception, limited access to birth control methods, improper contraceptive use, or experiences of sexual violence. Restricted availability of potent contraception elevates the likelihood of unplanned pregnancies by diminishing individuals’ autonomy concerning their reproductive decisions. Hormonal IUDs demonstrate high efficacy in preventing pregnancy, boasting a failure rate of less than 1%. They offer prolonged protection, lasting 3 to 7 years, depending on the specific model, making them a trustworthy choice for individuals aiming to prevent unwanted pregnancies. As an illustration, in July 2025, data from the Society for Family Planning, a US-based professional organization, indicated that abortions climbed to 1.14 million in 2024, up from 1.05 million in 2023. Consequently, the uptick in unwanted pregnancies is propelling the expansion of the hormonal intrauterine devices market.

What Segmentation Levels Are Considered In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Projected To Affect The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies within the hormonal intrauterine devices market are concentrating on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), designed to alleviate menstrual bleeding and cramps. These levonorgestrel intrauterine devices (IUDs) are long-term birth control options inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device serves two primary functions, offering up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive action derives from its ability to make cervical mucus denser, thereby stopping sperm from reaching the uterus. For heavy bleeding, it operates by thinning the uterine lining, which helps to decrease menstrual flow.

Which Leading Firms Are Contributing To The Growth Of The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Read the full hormonal intrauterine devices (iuds) market report here:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Which Regions Are Projected To Dominate The Hormonal Intrauterine Devices (IUDs) Market In The Coming Years?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hormonal Intrauterine Devices (IUDs) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Hormonal Intrauterine Devices (IUDs) Market?

The market for hormonal intrauterine devices (IUDs) has experienced rapid expansion in its size over recent years. This market is projected to expand from $2.87 billion in 2025 to $3.18 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to several factors, including heightened awareness regarding family planning alternatives, the broadening scope of women’s reproductive healthcare programs, a growing inclination towards long-acting contraceptive methods, the widespread availability of hormone-releasing devices, and backing from various public health campaigns.

The market for hormonal intrauterine devices (iuds) is projected to experience substantial expansion in the coming years. This market is anticipated to reach $4.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this growth during the projection period include a heightened need for non-surgical birth control options, an elevated emphasis on managing menstrual health, broader availability in developing regions, increased funding for women’s health innovations, and advancements in hormone delivery systems. Key trends anticipated within the forecast timeframe encompass a greater uptake of low-dose hormonal iuds, an escalating desire for long-acting reversible birth control, a developing inclination towards frameless device configurations, an expansion of iud uses for therapeutic purposes, and a strengthened commitment to patient comfort and safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Which Drivers Are Supporting The Rise Of The Hormonal Intrauterine Devices (IUDs) Market?

The escalating number of unwanted pregnancies is projected to fuel the expansion of the hormonal intrauterine devices market. Unwanted pregnancies are defined as conceptions that are not planned or desired at the time of their occurrence. These can arise from various factors, including contraceptive failure, inadequate access to birth control methods, incorrect application of contraception, or sexual violence. Restricted availability of effective contraception elevates the likelihood of unwanted pregnancies by diminishing individuals’ autonomy over their reproductive choices. Hormonal IUDs prove highly efficient in averting pregnancy, showing a failure rate of less than 1%. They offer prolonged protection, typically spanning 3 to 7 years based on the device type, and stand as a reliable option for those seeking to avoid unwanted pregnancies. As an illustration, in July 2025, the Society for Family Planning, a US-based professional organization, stated that the number of abortions climbed to 1.14 million in 2024, an increase from 1.05 million recorded in 2023. Therefore, the rise in unwanted pregnancies is a primary driver for the growth of the hormonal intrauterine devices market.

What Leading Segments Are Studied In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Trends Are Expected To Impact The Competitive Landscape Of The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies in the hormonal intrauterine devices market are concentrating on developing advanced solutions, such as levonorgestrel intrauterine devices (IUDs), to mitigate menstrual bleeding and cramps. Levonorgestrel intrauterine devices (IUDs) are long-lasting birth control methods implanted in the uterus that steadily release the hormone levonorgestrel to avert pregnancy. For example, in October 2024, Medicines360, a US-based nonprofit organization, introduced Avibela, a 52 mg levonorgestrel intrauterine device (IUD) in Zambia. This device offers two primary benefits: up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive action derives from its capacity to thicken cervical mucus, thereby stopping sperm from accessing the uterus. For managing heavy bleeding, it operates by thinning the uterine lining, which aids in decreasing menstrual flow.

Which Leading Companies Dominate The Hormonal Intrauterine Devices (IUDs) Market Share?

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

How Does The Hormonal Intrauterine Devices (IUDs) Market Perform Across Major Global Regions?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hormonal Intrauterine Devices (IUDs) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2026, By The Business Research Company

Contraceptive Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report

Hormonal Contraceptives Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Gynecological Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/gynecological-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the hormonal intrauterine devices (iuds) market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Hormonal Intrauterine Devices (IUDs) Market Today And What Will It Reach By 2029?

The market for hormonal intrauterine devices (IUDs) has shown considerable expansion in recent years. It is anticipated to grow from $2.61 billion in 2024 to $2.87 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The historical increase can be attributed to the introduction of safer and more efficacious hormonal formulations, a heightened demand for extended-duration birth control options, increased endorsements from healthcare providers, greater public understanding of available contraceptive choices, and continuous advancements in medical technology and device engineering.

The hormonal intrauterine devices (iuds) market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $4.29 billion by 2029, achieving a compound annual growth rate (CAGR) of 10.6%. The expansion observed during the forecast period can be attributed to heightened awareness of birth control alternatives, a growing preference for long-acting reversible contraception, improvements in the safety and effectiveness of these devices, an increasing focus on personalized healthcare solutions, and more widespread access through healthcare providers. Significant trends foreseen in the forecast period involve technological progress in device development, greater customization of contraceptive choices, an increase in patient-centered healthcare models, a rising demand for environmentally friendly products, and the creation of new contraceptive offerings.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

What Factors Are Boosting The Hormonal Intrauterine Devices (IUDs) Market?

The projected expansion of the hormonal intrauterine devices market is anticipated due to the rise in unwanted pregnancies. These are defined as conceptions that occur without prior planning or desire. Such pregnancies may arise from multiple factors, such as failed contraception, limited access to birth control methods, improper contraceptive use, or experiences of sexual violence. When individuals have restricted access to reliable contraception, it heightens the likelihood of unwanted pregnancies, as it diminishes their autonomy in reproductive decisions. Hormonal IUDs offer significant efficacy in preventing conception, exhibiting a failure rate of less than 1%. These devices provide extended protection for 3 to 7 years, based on the specific type, making them a dependable choice for individuals aiming to prevent unwanted pregnancies. An illustrative example comes from August 2023, where data from the Office for Health Improvement & Disparities, a UK-based governmental unit of the UK’s Department of Health and Social Care, revealed that from January to June 2022, residents of England and Wales underwent 123,219 abortions. This represented a 17% increase when contrasted with the corresponding timeframe in 2021. Consequently, the rising incidence of unwanted pregnancies is a primary factor fueling the expansion of the hormonal intrauterine devices market.

How Is The Hormonal Intrauterine Devices (IUDs) Market Categorized By Application, Type, And Region?

The hormonal intrauterine devices (iuds)market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

What Key Trends Are Driving Growth In The Hormonal Intrauterine Devices (IUDs) Market?

Leading companies within the hormonal intrauterine devices market are prioritizing the creation of advanced products, such as levonorgestrel-releasing intrauterine systems, to deliver more tailored contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices designed to steadily release levonorgestrel, a synthetic progestin, into the uterus. This hormone functions by thickening cervical mucus and modifying the uterine lining, thereby preventing sperm from reaching the egg. For example, in November 2022, Medicines360, a US-based pharmaceutical organization dedicated to enhancing women’s access to essential medicines and health products, unveiled the U.S. Food and Drug Administration (FDA)-approved LILETTA. LILETTA is recognized as one of the longest-lasting hormonal IUDs in the U.S., approved for contraception for up to 8 years and for treating heavy menstrual bleeding for up to 5 years. It demonstrates approximately 99% effectiveness in averting pregnancy across diverse populations. The device includes an ergonomic inserter for simple placement on the same day as a consultation and can be removed by a healthcare provider whenever desired. Available by prescription, LILETTA is offered at a reduced cost via the 340B drug pricing program, reinforcing Medicines360’s commitment to improving access to women’s healthcare.

Who Are The Global Leaders Steering The Hormonal Intrauterine Devices (IUDs) Market Forward?

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Hormonal Intrauterine Devices (IUDs) Market?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Handheld Surgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/handheld-surgical-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Hormonal Intrauterine Devices (IUDs) Industry In 2025?

The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.61 billion in 2024 to $2.87 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the development of safer and more effective hormonal formulations, rising demand for long-term birth control solutions, increasing healthcare provider recommendations, greater public awareness of contraceptive options, and advancements in medical technology and device design.

The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.29 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising awareness of contraceptive choices, increasing preference for long-acting reversible contraception, advancements in device safety and efficacy, growing emphasis on personalized healthcare, and broader availability through healthcare providers. Major trends in the forecast period include advancements in device technology, increasing personalization of contraceptive options, growth in patient-centric healthcare approaches, rising demand for sustainable and eco-friendly products, development of new contraceptive products.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Which Major Market Drivers Are Shaping The Future Of The Hormonal Intrauterine Devices (IUDs) Market?

The increase in unwanted pregnancies is expected to propel the growth of the hormonal intrauterine devices market going forward. Unwanted pregnancies refer to pregnancies that are not planned or desired at the time of conception. These pregnancies can occur for various reasons, including contraceptive failure, lack of access to birth control, incorrect use of contraception, or sexual violence. Limited access to effective contraception increases the risk of unwanted pregnancies by reducing individuals’ control over their reproductive choices. Hormonal IUDs are highly effective at preventing pregnancy, with a failure rate of less than 1%. They provide long-term protection (3 to 7 years, depending on the type) and are a reliable option for those seeking to avoid unwanted pregnancies. For instance, in August 2023, according to the Office for Health Improvement & Disparities, a UK-based governmental unit within the UK’s Department of Health and Social Care, from January to June 2022, residents of England and Wales had 123,219 abortions, marking a 17% increase compared to the same period in 2021. Therefore, the increase in unwanted pregnancies is driving the growth of the hormonal intrauterine devices market.

What Are The Major Segment Types Covered In The Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices (iuds)market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

How Are Trends Influencing The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices market are focused on developing advanced products, such as levonorgestrel-releasing intrauterine systems, to provide more personalized contraceptive solutions for women. Levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that release a steady dose of levonorgestrel, a synthetic progestin, into the uterus. This hormone thickens cervical mucus and alters the uterine lining to prevent sperm from reaching the egg. For instance, in November 2022, Medicines360, a US-based pharmaceutical organization focused on improving women’s access to essential medicines and health products, introduced the U.S. Food and Drug Administration (FDA)-approved LILETTA. LILETTA is one of the longest-lasting hormonal IUDs in the U.S. and is approved for up to 8 years of contraception and up to 5 years for treating heavy menstrual bleeding. It is approximately 99% effective in preventing pregnancy across diverse populations. The device features an ergonomic inserter for easy placement on the same day as a consultation and can be removed at any time by a healthcare provider. It is available by prescription, and LILETTA is offered at a reduced cost through the 340B drug pricing program, supporting Medicines360’s mission to improve access to women’s healthcare.

Which Key Players Are Driving Competition In The Hormonal Intrauterine Devices (IUDs) Market?

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

What Regional Growth Trends Are Shaping The Hormonal Intrauterine Devices (IUDs) Market Outlook?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hormonal Intrauterine Devices (IUDs) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Browse Through More Reports Similar to the Global Hormonal Intrauterine Devices (IUDs) Market 2025, By The Business Research Company

Hormonal Contraceptives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Handheld Surgical Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/handheld-surgical-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Hormonal Intrauterine Devices (IUDs) Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for hormonal intrauterine devices (IUDs) has seen a quick expansion in previous years. It’s projected to increase from $2.61 billion in 2024 to $2.87 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors such as the creation of safer and enhanced hormonal solutions, a surge in demand for long-term contraceptive methods, increasing suggestions from healthcare professionals, heightened public knowledge on birth control choices, and progression in medical tech and device structure were contributing elements to the growth observed in the past period.

The market size for hormonal intrauterine devices (iuds) is projected to experience significant growth in the coming years, reaching $4.29 billion in 2029 with a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period can be tied to increasing awareness of contraceptive options, a rising preference for durable, reversible contraception, improvements in the safety and efficiency of the devices, an expanding focus on personalized healthcare, and wider accessibility through healthcare professionals. The forecast period is also expected to witness trends such as advancements in contraceptive device technology, increased tailoring of contraceptive options to individual needs, the growth in patient-centered healthcare methodologies, a heightened demand for sustainable and green products, and the invention of new contraceptive products.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hormonal Intrauterine Devices (IUDs) Market?

The anticipated rise in unplanned pregnancies is set to fuel the expansion of the hormonal intrauterine devices market. Unplanned pregnancies are those that weren’t anticipated or desired at the point of conception, and they can happen due to various factors such as contraceptive failure, unavailability of birth control, misuse of contraception, or sexual violence. The lack of adequate access to effective contraception amplifies the risk of unplanned pregnancies as it diminishes people’s control over their reproduction choices. Hormonal IUDs, being extremely effective in preventing conception with a less than 1% failure rate, offer lasting protection (from 3 to 7 years, depending on the model) and stand out as a trustworthy solution for those looking to prevent unplanned pregnancies. For example, data from the Office for Health Improvement & Disparities, a government entity of the Department of Health and Social Care of the UK, recorded that residents of England and Wales underwent 123,219 abortions from January to June 2022, reflecting a 17% increase from the same timeline in 2021. Therefore, the hormonal intrauterine devices market is experiencing growth driven by the rise in unplanned pregnancies.

Which Key Market Segments Comprise the Hormonal Intrauterine Devices (IUDs) Market and Drive Its Revenue Growth?

The hormonal intrauterine devices (iuds)market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Which Areas Are Leading Regions in the Hormonal Intrauterine Devices (IUDs) Market Expansion Across the Globe?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theHormonal Intrauterine Devices (IUDs) Market Over the Coming Years?

Prominent companies in the hormonal intrauterine devices market are concentrating on the creation of improved products such as levonorgestrel-releasing intrauterine systems, aiming to offer more customized contraceptive options for women. The levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that consistently discharge a dose of levonorgestrel, a man-made progestin, into the uterus. This hormone makes the cervical mucus thick and modifies the uterine lining to stop sperm from making contact with the egg. For example, Medicines360, a pharmaceutical entity based in the United States and committed to enhancing women’s reach to vital medicines and health goods, launched the FDA-approved LILETTA in November 2022. With approval for up to 8 years of contraception and up to 5 years for heavy menstrual bleeding treatment, LILETTA is one of the most enduring hormonal IUDs in the U.S. It is nearly 99% successful in warding off pregnancy across diverse groups. The device, equipped with an ergonomic inserter for easy positioning during a consultation, can be removed by a healthcare professional at any time. LILETTA is available on prescription and is offered at a discounted rate via the 340B drug pricing program, furthering Medicines360’s objective to boost women’s healthcare accessibility.

View the full report here:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

How Is the Hormonal Intrauterine Devices (IUDs) Market Conceptually Defined?

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices inserted into the uterus that release progestin, a synthetic hormone. They prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to hinder implantation, and sometimes suppressing ovulation. They can also reduce menstrual bleeding and cramping and may even stop periods altogether.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Hormonal Intrauterine Devices (IUDs) Market From 2025 To 2029?

The market size of hormonal intrauterine devices (IUDs) has seen impressive growth recently. The market, which was worth $2.61 billion in 2024, is expected to increase to $2.89 billion in 2025 with a compound annual growth rate (CAGR) of 11.0%. This substantial growth during the historic period can be accredited to the evolution of safer and more efficient hormonal formulations, an upsurge in the demand for long-term contraception solutions, an increase in healthcare provider recommendations, heightened public understanding of birth control options, and progress in medical technology and device design.

What Is the Projected Market Size of the Hormonal Intrauterine Devices (IUDs) Market?

The market for hormonal intrauterine devices (IUDs) is predicted to undergo substantial expansion in the coming years. The market will escalate to $4.34 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. Factors such as increasing consciousness about birth control options, a growing fondness for durable reversible contraception, progress in device reliability and effectiveness, a heightened focus on individualized healthcare and broader access via healthcare professionals, all contribute to this expected growth in the forecast period. Crucial trends during this period will comprise of technological advancements in devices, personalized contraception choices, the surge of patient-oriented healthcare strategies, an increased call for green and eco-friendly products and creation of novel contraceptive items.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp

Who are the Major Competitors in the Hormonal Intrauterine Devices (IUDs) Market Outlook?

Major companies operating in the hormonal intrauterine devices (IUDs) market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Bharat Serums and Vaccines Limited, Teva UK Limited, EurimPharm Produktions GmbH, HRA Pharma SAS, Medicines360, Hll Lifecare Limited, Pregna International Ltd., Allergan plc, Actavis Inc., DKT WomanCare Global, CrossBay Medical Inc., SMB Corporation of India, Oy Leiras, OCON Healthcare

What Is Fueling Growth in the Hormonal Intrauterine Devices (IUDs) Market?

The hormonal intrauterine devices market is expected to grow due to a rise in unwanted pregnancies. Unwanted pregnancies are those that were unplanned or not wanted at the time they were conceived. Reasons for such pregnancies include contraceptive failure, limited access to birth control methods, misuse of contraception, and incidents of sexual violence. Lack of access to effective contraception methods makes more people prone to unwanted pregnancies as it diminishes their ability to manage their reproductive choices effectively. Hormonal IUDs are lauded for their efficacy in preventing pregnancies, boasting a failure rate of less than 1%. They offer long-lasting protection that can last between 3 and 7 years, depending on the type of IUD, proving them a dependable choice for those wanting to prevent unwanted pregnancies. For example, in August 2023, the Office for Health Improvement & Disparities, a governmental organization in the UK under the Department of Health and Social Care, reported that from January to June 2022, there were 123,219 abortions performed in England and Wales, indicating a 17% rise compared to the same timeframe in 2021. Consequently, the growth of the hormonal intrauterine devices market is being spurred by the rise in unwanted pregnancies.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp

Which Hormonal Intrauterine Devices (IUDs) Market Segments Are Growing the Fastest?

The hormonal intrauterine devices (IUDs) market covered in this report is segmented –

1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices

2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices

3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices

4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications

Subsegments:

1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions

2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions

3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

Which Industry Trends Are Shaping the Future of the Hormonal Intrauterine Devices (IUDs) Market?

Key players in the hormonal intrauterine devices sector are concentrating on the creation of cutting-edge goods such as levonorgestrel-releasing intrauterine systems to provide more tailored contraceptive choices for women. These systems, also known as LNG-IUS, are hormonal intrauterine devices that consistently deliver levonorgestrel, an artificial progestin, to the uterus, thickening cervical mucus and transforming the uterine lining to hinder sperm from contacting the egg. For example, Medicines360, a pharmaceutical firm in the United States dedicated to enhancing women’s access to critical medicines and healthcare products, launched LILETTA, approved by the U.S. Food and Drug Administration (FDA) in November 2022. LILETTA is among the most durable hormonal IUDs available in the United States, with approval for up to 8 years of contraception and up to 5 years for addressing heavy menstrual bleeding. The device has an approximately 99% success rate in preventing pregnancy among various populations. It comes with a user-friendly inserter for ease of fitting on the day of consultation and can be removed at any point by a healthcare professional. It can be obtained via prescription and is offered at a lower price through the 340B drug pricing scheme, reflecting Medicines360’s commitment to improving access to women’s healthcare.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hormonal-intrauterine-devices-iuds-global-market-report

Which Countries Are Leading the Hormonal Intrauterine Devices (IUDs) Market?

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091

This Report Delivers Insight On:

1. How big is the hormonal intrauterine devices (iuds) market, and how is it changing globally?

2. Who are the major companies in the hormonal intrauterine devices (iuds) market, and how are they performing?

3. What are the key opportunities and risks in the hormonal intrauterine devices (iuds) market right now?

4. Which products or customer segments are growing the most in the hormonal intrauterine devices (iuds) market?

5. What factors are helping or slowing down the growth of the hormonal intrauterine devices (iuds) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model